Shyam Lal M
Scientist B
Department of Science and Technology
Institute of Nanotechnology
India
Biography
Educational Qualification: Ph.D Biochemistry, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India (2015). M.Sc Biochemistry, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Gachibowli, Andhra Pradesh, India (2009). B.Sc Biotechnology, Osmania University, Hyderabad, Andhra Pradesh, India (2007). Positions Held :: Scientist B, Institute of Nano Science and Technology, Mohali, Punjab, India (4th Feb 2015 onwards) Research Fellow, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India (7/2011 – 9/2011). Research Fellow, Department of Zoology, Faculty of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, India (8/2010 - 6/2011). Awards : Awarded Bill Melinda Gates-ICID Travel Grant for presenting work at ICID March 2-5, 2016, Hyderabad, India. Awarded International Travel Award from ICMR for presenting work at International Congress & Exhibition on Nanobiotechnology organized by Centre of Nanotechnology from June 2- 4th 2014 in Munster, Germany. Awarded Rajiv Gandhi National Fellowship 2011-12 by University Grants Commission, New Delhi, India for pursuing Ph.D.
Research Interest
Developing targeting moieties for nanoparticle drug delivery towards visceral leishmaniasis Nano therapeutics using biocompatible and biodegradable nanoparticles Nanomaterials and biological systems: Understanding the interactions
Publications
-
S.L. Mudavath, M. Rai, M. Talat, O.N. Srivastava, S. Sundar. Amine modified graphene mediated drug delivery of Amphotericin B for the treatment of visceral leishmaniasis. International Journal of Infectious Diseases 21S (2014) 1–460.
-
Prakash Saudagar, Mudavath SL, Pipas Saha, Anil K. Saikia, Shyam Sundar and Vikash Kumar Dubey. In vivo assessment of antileishmanial property of 4-(4, 4, 8-Trimethyl 7-oxo-3-oxabicyclo [3.3.1] non-2-yl)-benzoic acid methyl ester, an oxabicyclo [3.3.1] nonanones, in hamster model; Letters in Drug Design & Discovery; 11, 937-939.
-
Kumar D, Khanal B, Tiwary P, Mudavath SL, Tiwary NK, Singh R, Koirala K, Boelaert M, Rijal S, Sundar S. Comparative Evaluation of Blood and Serum Samples in Rapid Immunochromatographic Tests for Visceral Leishmaniasis. J Clin Microbiol. 2013 Dec; 51(12):3955-9. doi: 10.1128/JCM.01232-13. Epub 2013 Sep 18.
-
Mudavath SL, Talat M, Rai M, Srivastava ON, Sundar S; Characterization and evaluation of amine modified graphene Amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies ; Drug Design, Development and Therapy; 2014 Sep 4;8:1235-47. doi: 10.2147/DDDT.S63994. eCollection 2014.
-
Niraj Kumar Vishwakarma, Vijay Kumar Patel, Ravi Kumar, Shyam Lal Mudavath, Tanu Gupta, Kalyan Ramesh, Karun Jana, P. K. Dutta, Pralay Maiti, Nira Misra, Medicherla V Jagannadham, Shyam Sundar, Biswajit Ray, Galactosylated Chitosan for Enhanced and Efficient Antimicrobial and Antileishmanial Activities: A Novel Approach, Asian Chitin J, 11 (2), 11-18. 2015
-
SL Mudavath, M Talat, M Rai, ON Srivastava, S Sundar , An oral formulation of Amphotericin B for the treatment of visceral Leishmaniasis: f-Gr-AmB, International Journal Of Infectious Diseases, 45, 367. 2016
